DRG’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key type 1 diabetes  patient populations covering 171 countries and more than 99% of the global population, delivered in an interactive dashboard-style download kfhkdfh

Use the Extrapolated Worldwide Coverage dashboard to do the following:

  • View 10-year forecasts of the diagnosed incident cases and diagnosed prevalent cases for all 171 countries, stratified by region and World Bank income status.
  • Aggregate country-level estimates into region-level estimates, according to user preference or as required by regulators for orphan drug designations.
  • Visualize global correlations between disease risk or patient population size and key indicators of market opportunity such as GDP per capita and healthcare spend per capita.
  • Generate and export global heat maps of disease risk or patient population size.

The Extrapolated Worldwide Coverage dashboard is available as an Excel file in the “Downloads” section. It is available for purchase by clients who subscribe to all 45 countries covered by DRG Epidemiology. For subscription and entitlement queries, please contact DRG.support@clarivate.com.


Table of contents

  • Lag Topic - Landscape - Extrapolated Worldwide Coverage-1600685872
    • text test
    • Folder test
      • Etiology and Pathophysiology
        • Expert Insight
        • Disease Overview
        • Natural History
        • Classification of Atrial Fibrillation
        • Major Clinical Manifestations of Atrial Fibrillation
        • Signs and Symptoms of Atrial Fibrillation
        • The Cardiac Conduction System
        • Phases and Ionic Currents of the Human Cardiac Action Potential
        • Comparison of ECG Recordings from Healthy and AF Patients
        • Electrical Remodeling
        • Contractile Remodeling
        • Structural Remodeling
        • Ion Channels and Gap Junction Abnormalities
        • Ion-Channel Expression Changes in Human Atrial Fibrillation
        • Inflammatory Factors Contributing to Atrial Fibrillation
        • Electrophysiological Mechanisms
        • The Role of Genetics in Atrial Fibrillation Induction
        • Atrial Fibrillation Drug Targets and Rationale
        • Antithrombotic Drug Targets
        • table
      • text node
      • test
    • folder save
      • test text test
      • test
      • text node
    • text node
    • table test
    • test by priya
    • Folder test test
      • text
    • 1st folder
      • text

Author(s): Joseph Granato, M.P.H.; Nicole Zhang, M.P.H.

Joseph Granato, M.P.H., is a senior epidemiologist at DRG, part of Clarivate. Before joining DRG, he worked with the Monroe County Health Department on the surveillance of reportable diseases, including dengue fever. He received his M.P.H. from Des Moines University, where he worked on several population health projects, including tick-borne diseases. He also holds a B.S. in animal science from the University of Tennessee.

Nicole Zhang, M.P.H., is an epidemiologist at DRG, part of Clarivate. Prior to joining DRG, she worked as a research analyst at Massachusetts General Hospital, where she independently managed data from a food information survey conducted in Chelsea, Massachusetts. She has also worked for the Massachusetts Department of Public Health, conducting secondary research in the field of gestational diabetes. She holds an M.P.H. from Tufts Medical School, where she specialized in epidemiology and biostatistics. She also holds a B.A. in chemistry and statistics from Mount Holyoke College.

Related Reports

Type 1 Diabetes - Landscape & Forecast - Disease Landscape & Forecast

The number of treatment options continues to increase in the T1D space. Existing agents fail to provide sustained and intrinsic control of

View Details

Type 1 Diabetes - Epidemiology - Mature Markets

DRG Epidemiology's coverage of type 1 diabetes comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of type 1 di...

View Details